CYCLOALKYL CARBOXYLIC ACID DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF

SMALL MOLECULE ANTAGONISTS OF PF4

LPAR1 ANTAGONISTS AND USES THEREOF

ARYL CYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAME, AND METHOD FOR USE THEREOF

ARYLCYCLOHEXANEDIONE DERIVATIVE OR SALT THEREOF, PEST CONTROL AGENT CONTAINING SAID COMPOUND, AND METHOD FOR USING SAME

COMBINATORIAL ANTIBIOTIC DERIVATIVES BASED ON SUPRAMOLECULAR STRUCTURES

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

Photoinitators

Halogenated benzotropolones as ATG4B inhibitors

RUNX2 transcription factor inhibitors and uses thereof

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

Method of preparing substituted bicyclo[1.1.1] pentanes

Farnesoid X receptor agonists and uses thereof

Agonists of protein tyrosine phosphatase SHP-1

Asymmetric Bisamidation of Malonic Ester Derivatives

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

SHIP1 modulators and methods related thereto

METHODS FOR INHIBITING MUSCLE ATROPHY

Inhibitors of histone deacetylase

Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV

RUNX2 transcription factor inhibitors and uses thereof

INHIBITORS OF HISTONE DEACETYLASE

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

ABIETANE-TYPE DITERPENOIDS

Use of agonists of formyl peptide receptor 2 for treating dermatological diseases

Preparation and biological evaluation of viridicatumtoxin analogs

Processes and Intermediates for Preparing a Macrocyclic Protease Inhibitor of HCV

Thickening/stabilizing agent and thickened/stabilized composition using the same

Inhibitors of histone deacetylase

SHIP1 modulators and methods related thereto

Inhibitors of histone deacetylase

Polyimide resin

Composition for treatment of pathogens that are resistant to tetracyclines

Antagonists of the toll-like receptor 1/2 complex

Substituted aminobutyric derivatives as neprilysin inhibitors

Polyimide precursor and polyimide

Norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic dianhydride, norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic acid and ester thereof, method for producing norbornane-2-spiro-α-cycloalkanone-α′-spiro-2″-norbornane-5,5″,6,6″-tetracarboxylic dianhydride, polyimide obtained by using the same, and method for producing polyimide

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

Treatment of cancer, inflammatory disease, and autoimmune disease

METHOD OF TREATING CONTRAST-INDUCED NEPHROPATHY

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORS

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

PROCESS FOR PRODUCING 3-ALKOXY-2-AMINO-6-FLUOROBICYCLO [3.1.0] HEXANE-2,6-DICARBOXYLIC ACID DERIVATIVE AND INTERMEDIATE THEREOF

Inhibitors of histone deacetylase

Inhibitors of histone deacetylase

Methods for inhibiting muscle atrophy

Compounds and methods for altering lifespan of eukaryotic organisms

NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC ACID AND ESTER THEREOF, METHOD FOR PRODUCING NORBORNANE-2-SPIRO-alpha-CYCLOALKANONE-alpha'-SPIRO-2''-NORBORNANE-5,5'',6,6''-TETRACARBOXYLIC DIANHYDRIDE, POLYIMIDE OBTAINED BY USING THE SAME, AND METHOD FOR PRODUCING POLYIMIDE

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Substituted aminobutyric derivatives as neprilysin inhibitors

Process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative and intermediate thereof

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators

Method of treating contrast-induced nephropathy

1,5-diphenyl-penta-1,4-dien-3-one compounds

Compounds and methods for the treatment of pain and other diseases

Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma

Substituted aminobutyric derivatives as neprilysin inhibitors

Compositions and methods for inhibiting growth and metastasis of melanoma

NOVEL COMPOUND, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF

Alpha-hydroxyketones

Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof

Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Novel 4-Dedimethylaminotetracycline derivatives

Adhesion promoting photoinitiators for UV cured coatings over metal surfaces

Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof

Compositions and methods for inhibiting growth and metastasis of melanoma

Mutilin-Derivative Substituted at Position 12

Human G protein-coupled receptor and modulators thereof for the treatment of cell death-related disorders

Structural analogs of corosolic acid having anti-diabetic and anti-inflammatory properties

Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof

Crystalline form of oxcarbazepine

Bicyclic derivatives that modulate voltage-gated potassium channels and methods of use thereof

Compounds and compositions for delivering active agents

Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

Compounds and compositions for delivering active agents

4-dedimethylaminotetracycline derivatives

Compounds and compositions for delivering active agents